Connect with us

Headlines

2 Longtime Essilor of America Leaders Retire

mm

Published

on

Both began their careers with Varilux.

DALLAS – Essilor of America announced the retirement of longtime company executives Bob Colucci and Dr. Rodney Tahran at the end of 2017.

Colucci has been president of the Independent Distribution Division of Essilor of America Inc. since October 2004. IDD is dedicated to supporting independently owned and operated optical labs with products, programs and strategies to grow their business. He began his career with Essilor in 1989 as director of sales for Varilux Corp. He was promoted to vice president of sales in early 1991 and had an active role over the years in the rapid growth of the Varilux product line.

In 1996, Essilor Lenses reorganized into distinct business units focusing on unique customer segments and Colucci served as senior vice president, general manager wholesale group, Essilor Lenses. In 1997, he was elected by U.S. employees to serve on the board of directors of Valoptec Association, the association that represents Essilor employee shareholders, a position he held through April 2006.

In 1999, Essilor International shareholders elected Colucci as a member of the Essilor board of directors, a role he held until March 2004. Also in 1999, he assumed the position of senior vice president, sales and marketing, for Essilor Laboratories of America.

Advertisement

Colucci became the chairman of Essilor Vision Foundation in 2012. The foundation is committed to eliminating poor vision and its lifelong consequences, and to providing underprivileged people the opportunity to live a better life through better sight.

With Colucci’s retirement, Essilor of America has created the Wholesale Business group led by Senior Vice President John Walborn. This group, which includes IDD, Integrated Independents, Essilor Prescription Safety Eyewear, Shore, KBCo and X-Cel Lens companies, consolidates most of Essilor’s lens businesses under the leadership of Walborn and his team. Shon Bjornberg, vice president IDD, will take over day-to-day operations of IDD. Colucci will remain chairman of Essilor Vision Foundation and on the board of the Vision Council in 2018.

Additionally, Tahran, vice president of professional relations, is retiring after 36 years with the company. Tahran, who is also an adjunct professor at the Southern California College of Optometry and the Pacific University College of Optometry in Forest Grove, OR, began his career with Essilor as director of professional services for Varilux Corp.

Tahran is co-creator of the popular Essilor Optometry Student Bowl held annually during Optometry’s Meeting. This year marked the 26th anniversary of the OSB, a game show-style event where students from all 24 schools and colleges of optometry answer optometry-related questions in an effort to win money and the coveted Ventura Cup crystal trophy.

During his career, Tahran traveled internationally to lecture in places including Europe, China, Singapore, North Africa and Australia. He also has been published in numerous ophthalmic trade publications including Optometric Monthly, Optometric Management, Review of Optometry and the Journal of the American Optometric Association.

Tahran is a member of the American Optometric Association and a fellow of the American Academy of Optometry. He serves as the vice chair of the Marshall B. Ketchum University Board of Trustees.

Advertisement

Essilor stated in a press release: “Replacing someone like Rod is a difficult task and his tenure with Essilor has laid a solid foundation for the importance of having optometrists on the industry side of the business. As a leader known for its innovation and realizing all the value Rod has brought to the organization and the industry, Essilor is implementing a plan that will continue to serve its customers while also filling the gap left by Dr. Tahran.”

​In that vein, the company announced that Dr. Ryan Parker is joining the professional relations team at Essilor of America. Parker has been a consultant for EOA since 2013 and will join the team on a full-time basis.

“His dynamic style, keen clinical and management insights along with a successful history of growing a thriving independent practice in Oklahoma are only a few of the many skills Parker brings to the team,” the company stated.

Advertisement

SPONSORED VIDEO

SPONSORED BY REICHERT

When You’re Passionate About Eye Care, the Right Technology Matters

Lisa Genovese, O.D., strives to give her patients the very best. At Insight Eye Care’s multiple locations, Dr. Genovese provides optimal care for her patients using the Reichert® Phoroptor® VRx Digital Refraction System. In this second Practice Profile Video from Reichert’s “Passionate About Eye Care” series, take a closer look and see how this eye care professional achieved a better work-life balance with equipment that’s designed and engineered in the U.S.A.

Promoted Headlines

Headlines

FDA Approves First Contact Lens to Slow Myopia Progression in Children

The approval was granted to CooperVision. 

mm

Published

on

The U.S. Food and Drug Administration has approved the first contact lens indicated to slow the progression of myopia in children between the ages of 8 and 12 years old.

The FDA granted approval of MiSight, a single-use disposable soft contact lens, to CooperVision Inc.

Podcast: What Exactly Does it Take to Become America’s Finest Optical Retailer?
INVISION Podcast

Podcast: What Exactly Does it Take to Become America’s Finest Optical Retailer?

Podcast: Why Optical (and Especially Optical Retail) Is Lagging Behind Other Industries
INVISION Podcast

Podcast: Why Optical (and Especially Optical Retail) Is Lagging Behind Other Industries

Podcast: What the Heck is Marketing? And What Should ECPs Focus on to Attract New Clients?
INVISION Podcast

Podcast: What the Heck is Marketing? And What Should ECPs Focus on to Attract New Clients?

“Today’s approval is the first FDA-approved product to slow the progression of myopia in children, which ultimately could mean a reduced risk of developing other eye problems,” said Dr. Malvina Eydelman, director of the Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices in the FDA’s Center for Devices and Radiological Health.

Myopia is the most frequent cause of correctable visual impairment worldwide, the FDA noted in a press release announcing the approval. It is common in children and tends to increase as they get older.

CooperVision said in its own press release that MiSight is “the cornerstone of a comprehensive myopia management approach” that it will offer.

“We can’t overstate the importance and potential impact of this landmark decision on children’s vision, especially considering the rise in myopia’s severity and prevalence in the U.S. and worldwide,” said Daniel G. McBride, president of CooperVision. “Eye care professionals who embrace this breakthrough approach will improve the quality of life and eye health for so many children.”

The product will launch in the U.S. as part of a CooperVision myopia management initiative beginning in March 2020, according to the company’s release. The lens “is already being successfully worn by thousands of myopic children in other parts of the world, including Canada, the United Kingdom, Spain and Australia, where age ranges for initial fitting may vary.”

MiSight “has been recognized as one of the most innovative developments in eye health by the likes of the British Contact Lens Association and international industry media,” according to the release.

The MiSight soft contact lenses are meant to be worn daily to correct nearsightedness and slow the progression of myopia in children with healthy eyes. When placed on the eye, one part of the MiSight contact lens corrects the refractive error to improve distance vision in nearsighted eyes, similar to a standard corrective lens. In addition, concentric peripheral rings in the lens focus part of the light in front of the retina (the back of the eye). This is believed to reduce the stimulus causing the progression of myopia.

The approval of MiSight was based on data obtained from a prospective clinical trial at four clinical sites and real-world evidence. The safety and effectiveness of MiSight was studied in a three-year randomized, controlled clinical trial of 135 children ages 8 to 12 at the start of treatment who used MiSight or a conventional soft contact lens.

The trial showed that for the full three-year period, the progression in myopia of those wearing MiSight lenses was less than those wearing conventional soft contact lenses. In addition, subjects who used MiSight had less change in the axial length of the eyeball at each annual checkup. Over the course of the trial, there were no serious ocular adverse events in either arm of the study.

Additionally, to estimate the rate of vision-threatening corneal infections among children and adolescents who wear soft contact lenses daily, the FDA reviewed real world data from a retrospective analysis of medical records of 782 children ages 8 to 12 years old from seven community eyecare clinics. The results showed a rate comparable to the rate of ulcer cases among adults who wear contact lenses daily.

As part of the approval of MiSight, the sponsor is required to conduct a postmarket study of the contact lenses to further evaluate the safety and effectiveness of the product as indicated.

Continue Reading

Headlines

LASIK Should Be Banned, Says Former FDA Adviser

He regrets voting to approve the treatment.

mm

Published

on

A retired U.S. Food and Drug Administration adviser says LASIK eye surgery should be removed from the market.

Morris Waxler voted to approve to treatment, but now wishes he hadn’t, CBS News reports. He has re-examined the data.

“Essentially we ignored the data on vision distortions that persisted for years,” he told CBS.

His analysis suggests that 10 percent to 30 percent of patients experience complications. He asked the FDA in 2011 to issue a voluntary recall of the treatment, but the FDA declined to do so.

The FDA recently told CBS that it “has not found any new safety concerns associated with LASIK devices.”

CBS News quoted several patients saying they’d been harmed by LASIK.

Abraham Rutner, for example, said that he had double vision and that “around the lights [was] like having starbursts.” He notes, however, that his vision is improved by approximately 90 percent.

Experts say pre-surgical screening is crucial to avoiding LASIK complications.

The key lies in “knowing who to operate on and who not to operate on and there are people who really should not have this procedure,” Dr. Jules Winokur told CBS News.

The FDA has issued an advisory on risks and how to find find the right doctor for LASIK.

Read more at CBS News

Continue Reading

Headlines

Video: Adorable Cat Melts Hearts By Trying on Eyewear for Children

Kids see that ‘if she can wear hers, they can wear them too.’

mm

Published

on

A rescue cat in Pennsylvania is getting attention for her role in making children feel comfortable with their eyeglasses.

Truffles happily wears brightly colored frames to set a good example for the young patients of A Child’s Eyes in Mechanicsburg, the Daily Mail reports.

“If a child is feeling a bit nervous I ask Truffles if she wants to show them her glasses,” says Danielle Crull, owner of the business. “When they see Truffles wearing them it’s a really good thing and shows that if she can wear hers, they can wear them too.”

A video of the cat trying on eyewear has been viewed millions of times.

Watch the video:

Continue Reading

Advertisement

Advertisement

Subscribe


BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Most Popular